14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BIVI
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

BioVie Inc stock price fell more than -5.32% Tuesday closing at $0.449
(Updated on Jun 25, 2024)

Sell candidate since Jun 25, 2024 PDF

The BioVie Inc stock price fell by -5.32% on the last day (Tuesday, 25th Jun 2024) from $0.474 to $0.449. During the last trading day the stock fluctuated 9.76% from a day low at $0.449 to a day high of $0.493. The price has been going up and down for this period, and there has been a -5.91% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -480 thousand shares and in total, 538 thousand shares were bought and sold for approximately $241.53 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.96% during the next 3 months and, with a 90% probability hold a price between $0.384 and $0.467 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BIVI Signals & Forecast

There are mixed signals in the stock today. The BioVie Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.461 and $0.473. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Friday, June 07, 2024, and so far it has risen 4.13%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for BioVie Inc stock

BioVie Inc finds support from accumulated volume at $0.440 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0438 between high and low, or 9.76%. For the last week the stock has had daily average volatility of 6.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BIVI) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect BioVie Inc to open at $0.463, and during the day (based on 14 day Average True Range), to move between $0.418 and $0.479, which gives a possible trading interval of +/-$0.0305 (+/-6.79%) up or down from last closing price. If BioVie Inc takes out the full calculated possible swing range there will be an estimated 13.59% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.440 (1.96%) than the resistance at $0.488 (8.82%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioVie Inc stock A Buy?

BioVie Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.991 Sell Candidate Downgraded

Predicted Opening Price for BioVie Inc of Wednesday, June 26, 2024

Fair opening price June 26, 2024 Current price
$0.463 ( 3.25%) $0.449

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BIVI

Fibonacci Support & Resistance Levels

Level Price
R3 0.507 13.01%
R2 0.490 9.28%
R1 0.480 6.98%
Price 0.449
S1 0.447 -0.475%
S2 0.436 -2.78%
S3 0.420 -6.51%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.534 18.89%
R2 0.493 9.78%
R1 0.488 8.82%
Price 0.449
S1 0.440 -1.96%
S2 0.437 -2.54%
S3 0.431 -3.97%

FAQ

What is the symbol for BioVie Inc Stock and on which exchange is it traded?
The symbol for BioVie Inc is BIVI and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell BioVie Inc Stock?
BioVie Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy BioVie Inc Stock?
BioVie Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioVie Inc Stock.

What's the current price of BioVie Inc Stock?
As of the end of day on the Jun 25, 2024, the price of an BioVie Inc (BIVI) share was $0.449.

What is the 52-week high and low for BioVie Inc Stock?
The 52-week high for BioVie Inc Stock is $5.82 and the 52-week low is $0.405.

What is the market capitalization of BioVie Inc Stock?
As of the Jun 25, 2024, the market capitalization of BioVie Inc is 28.923M.

When is the next earnings date for BioVie Inc?
The upcoming earnings date for BioVie Inc is Aug 21, 2024.
Click to get the best stock tips daily for free!

About BioVie Inc

BioVie BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for ... BIVI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT